Woodrow Wilson C/D
After providing a basic introduction to OTC derivatives, this session will discuss the evolving regulatory and legislative landscape for OTC derivatives, swap dealers and major swap participants. Issues will be addressed in connection with compliance requirements relating to swap dealers’ and MSPs' reporting obligations. The panel will also address legislative developments in connection with other duties imposed upon swap dealers and MSPs such as registration requirements, capital and margin requirements, the need for standards of conduct for risk disclosure and fair dealing, the application of making appropriateness or suitability determinations, and statutory disqualifications.
William McCoy, Managing Director, Morgan Stanley
Warren Davis, Of Counsel, Sutherland Asbill & Brennan
Armand Nakkab, Executive Director, Legal & Compliance, J.P. Morgan Chase
Ronald Oppenheimer, General Counsel, Vitol
Lawrence Patent, Of Counsel, K&L Gates
Athena Velie, Partner, McDermott Will & Emery